SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 105 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $425,000 | +11.0% | 7,100 | -15.2% | 0.13% | +1.6% |
| Q1 2018 | $383,000 | -1.5% | 8,370 | -14.2% | 0.13% | 0.0% |
| Q4 2017 | $389,000 | -5.6% | 9,760 | -5.2% | 0.13% | -5.9% |
| Q3 2017 | $412,000 | -54.9% | 10,290 | -51.5% | 0.14% | -47.9% |
| Q2 2017 | $914,000 | -6.3% | 21,214 | -31.9% | 0.26% | +12.5% |
| Q1 2017 | $975,000 | +24.0% | 31,141 | 0.0% | 0.23% | +28.9% |
| Q4 2016 | $786,000 | +0.1% | 31,141 | -1.9% | 0.18% | -3.2% |
| Q3 2016 | $785,000 | -43.2% | 31,741 | -53.2% | 0.19% | -48.0% |
| Q2 2016 | $1,383,000 | +158.0% | 67,881 | +93.3% | 0.36% | +109.4% |
| Q1 2016 | $536,000 | +18.1% | 35,125 | +4.0% | 0.17% | +18.8% |
| Q4 2015 | $454,000 | -10.3% | 33,790 | -6.3% | 0.14% | -12.7% |
| Q3 2015 | $506,000 | -51.2% | 36,060 | -40.9% | 0.16% | -47.3% |
| Q2 2015 | $1,036,000 | +40.6% | 60,990 | 0.0% | 0.31% | +39.7% |
| Q1 2015 | $737,000 | +120.0% | 60,990 | +51.0% | 0.22% | +88.2% |
| Q4 2014 | $335,000 | – | 40,380 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |